Table 3.
Magnitude of HBV markers among different study populations in different regions of Ethiopia from 1983 to 2011
| Other HBV markers | References | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sampling year | Study area | Study groups | Sampled population | HBsAg n (%) | anti-HBs, n (%) | anti-HBcAg, n (%) | anti-HBeAg, n (%) | HBeAg, n (%) | |
| 1983 | Nationwide | Gen. population, children & ANC attendants | 396 | 36 (9.1) | 221 (67.2)a | - | 19(55.9)d | 15(44.0)g | [85] |
| 1984 | Nationwide | General population | 500 | 31 (6.2) | 152 (30.4) | 16 (3.2) | 10(32.3)e | 8(25.8)e | [52] |
| 1987 | A. Ababa | Health workers | 432 | 39 (9.02) | 200 (46.3) | 316 (73.1) | - | - | [29] |
| 1989 | Nationwide | General population | 5265 | 569 (10.8) | 61.4b | 132 (2.5) | 298(57.1)f | 99(19.0)f | [26] |
| 1994 | A.Ababa | General population | 4736 | 292 (6.2) | 1796(40.7)c | 1734 (36.6) | - | 71/279 (25.4) | [27] |
| 1995 | A.Ababa | Chronic liver disease patients | 238 | 65 (27.0) | 131 (55.0) | - | - | - | [49] |
| 1998 | Immigrants to Israel | Familial members | 506 | 84 (16.6%) | - | - | - | 17/84(20.2) | [95] |
| 2007 | A. Ababa | HIV patients & VCT clients | 620 | 29 (4.7) | - | 277 (44.7) | - | 3/29(10.3) | [42] |
| 2010 | Gamo HP | Inpatients department clients | 556 | 26 (4.7) | - | 7 (1.4) | - | - | [33] |
| 2011 | A.Ababa | HIV patients | 500 | 15(3.0) | 58(11.6) | - | - | 3(0.6) | [53] |
aANC-Antenatal Care. bOnly the percentage was presented from the origional study. HBeAg and anti-HBeAg percentages were calculated on the basis of sample size of HBsAg positive individuals; e = 31, d = 34, f = 522 and g = 19. a = 329 and c = 4414 among HBsAg negatives